Inventor · disambiguated record
Andrey Loboda
Also filed as: LOBODA ANDREY
7 granted patents·12 pending applications·23 citations·filing 2004–2023
80Inventor score
Top patents by PatentIndex Score
19 records- 0182US10041129B2Immune gene signatures in cancerH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Aug 7, 2018·3 cites·15 claims
- 0280US7640114B2Method of diagnosis of cancer based on gene expression profiles in cellsWISTAR INST·Filed 2004·Granted Dec 29, 2009·10 cites·20 claims
- 0377US9404926B2Immune gene signatures in cancerMULÉ JAMES J·Filed 2011·Granted Aug 2, 2016·5 cites·21 claims
- 0471US7919261B2Methods for predicting treatment response based on the expression profiles of protein and transcription biomarkersMERCK SHARP & DOHME·Filed 2006·Granted Apr 5, 2011·3 cites·1 claims
- 0570US8392127B2Methods and gene expression signature for assessing growth factor signaling pathway regulation statusWATTERS JAMES·Filed 2009·Granted Mar 5, 2013·2 cites·7 claims
- 0668US2025356947A1Genome wide tumor derived gene expression based signatures associated with poor prognosis for melanoma patients with early stage diseaseMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0754US2014030255A1Methods of predicting cancer cell response to therapeutic agentsLOBODA ANDREY·Filed 2011·Application pending·0 cites
- 0850US2014031251A1Methods of classifying human subjects with regard to cancer prognosisYEATMAN TIMOTHY·Filed 2011·Application pending·0 cites
- 0948US2010284915A1Genes associated with chemotherapy response and uses thereofDAI HONGYUE·Filed 2007·Application pending·0 cites
- 1048US2022380854A1ANGIOGENESIS AND mMDSC GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTSMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 1146US2024317854A1Methods for treating cancer with anti-ilt3 antibodiesBRANDISH PHILIP E·Filed 2022·Application pending·0 cites
- 1246US2016312297A1Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1345US2022112564A1Gene expression based biomarker of tumor response to pd-1 antagonistsLOBODA ANDREY·Filed 2020·Application pending·0 cites
- 1444US2016312295A1Gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1544US2016304969A1Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonistsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1643US2014304845A1Alzheimer's disease signature markers and methods of useMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 1742US11326211B2Blood-based biomarkers of tumor sensitivity to PD-1 antagonistsMERCK SHARP & DOHME·Filed 2016·Granted May 10, 2022·0 cites·18 claims
- 1835US2010280987A1Methods and gene expression signature for assessing ras pathway activityLOBODA ANDREY·Filed 2010·Application pending·0 cites
- 1927US11377693B2System and methods for deriving gene signature biomarkers of response to PD-1 antagonistsAYERS MARK D·Filed 2015·Granted Jul 5, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Andrey Loboda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →